Gene expression analysis of publicly available datasets representing human AML samples revealed that reduced expression of TRAF6 is associated with mitochondrial function-related and disorder-related gene sets, such as Huntington’s, Parkinson’s, and Alzheimer’s diseases (Fig. 2A). Here, TRAF6 is linked to early-onset autosomal dominant Alzheimer disease.